These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 30747328)
1. A retrospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Wang T; Hu Y; He Y; Sun P; Guo Z Arch Gynecol Obstet; 2019 May; 299(5):1429-1435. PubMed ID: 30747328 [TBL] [Abstract][Full Text] [Related]
2. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer. Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141 [TBL] [Abstract][Full Text] [Related]
3. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer. Papadia A; Gasparri ML; Radan AP; Stämpfli CAL; Rau TT; Mueller MD J Cancer Res Clin Oncol; 2018 Jul; 144(7):1385-1393. PubMed ID: 29691646 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006). Altın D; Taşkın S; Ortaç F; Tokgözoğlu N; Vatansever D; Güler AH; Güngör M; Taşçı T; Beşe T; Turan H; Kahramanoğlu İ; Yalçın İ; Çelik Ç; Demirkıran F; Köse F; Arvas M; Ayhan A; Taşkıran Ç Gynecol Oncol; 2022 Mar; 164(3):492-497. PubMed ID: 35033380 [TBL] [Abstract][Full Text] [Related]
5. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. Soliman PT; Westin SN; Dioun S; Sun CC; Euscher E; Munsell MF; Fleming ND; Levenback C; Frumovitz M; Ramirez PT; Lu KH Gynecol Oncol; 2017 Aug; 146(2):234-239. PubMed ID: 28528918 [TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001). Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440 [TBL] [Abstract][Full Text] [Related]
7. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm. Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838 [TBL] [Abstract][Full Text] [Related]
8. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739). Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614 [TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis. Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899 [TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers. Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536 [TBL] [Abstract][Full Text] [Related]
11. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes? Ye L; Li S; Lu W; He Q; Li Y; Li B; Wang X; Yan Q; Wan X Oncologist; 2019 Dec; 24(12):e1381-e1387. PubMed ID: 31270269 [TBL] [Abstract][Full Text] [Related]
12. Sentinel Node Biopsy in Endometrial Cancer With Dual Cervical and Fundal Indocyanine Green Injection. Ruiz R; Gorostidi M; Jaunarena I; Goiri C; Aguerre J; Lekuona A Int J Gynecol Cancer; 2018 Jan; 28(1):139-144. PubMed ID: 29194192 [TBL] [Abstract][Full Text] [Related]
13. Prospective study of sentinel lymph node mapping for endometrial cancer. Togami S; Kawamura T; Fukuda M; Yanazume S; Kamio M; Kobayashi H Int J Gynaecol Obstet; 2018 Dec; 143(3):313-318. PubMed ID: 30125949 [TBL] [Abstract][Full Text] [Related]
14. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping. Sozzi G; Fanfani F; Berretta R; Capozzi VA; Uccella S; Buono N; Giallombardo V; Di Donna MC; Monterossi G; Restaino S; Capasso I; Dinoi G; Scambia G; Chiantera V Int J Gynecol Cancer; 2020 Nov; 30(11):1713-1718. PubMed ID: 32868384 [TBL] [Abstract][Full Text] [Related]
15. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure. Eoh KJ; Lee YJ; Kim HS; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW Surg Oncol; 2018 Sep; 27(3):514-519. PubMed ID: 30217312 [TBL] [Abstract][Full Text] [Related]
16. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015 [TBL] [Abstract][Full Text] [Related]